Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers

Julien Calderaro1,2, Jakob Nikolas Kather3,4

  • 1U955, INSERM, Créteil, France julien.calderaro@aphp.fr.

Gut
|November 20, 2020
PubMed
Summary

Artificial intelligence (AI) enhances histopathology analysis for gastrointestinal and liver cancers. AI tools can detect tumors, predict outcomes, and infer molecular changes from digital slides, aiding pathologists.

Related Concept Videos